FCF Yield

AbbVie's current FCF Yield of 4.4% means that for every $100 invested in the stock, the company generates $4.40 in free cash flow — the cash left after operating and capital expenses.

That yield sits just below the healthcare sector median of 4.5%, placing AbbVie in the 41st percentile among its sector peers, so it offers slightly less cash return than the typical company in its industry. The metric has been completely stable, with no change year-over-year or quarter-over-quarter (both +0.0%), and every quarterly value over the last eight periods was exactly 4.4%. A stable FCF Yield at this moderate level suggests neither a clear value opportunity nor a warning sign — investors can expect consistent cash generation without a catalyst for improvement or deterioration. Since the yield is near the sector median and has not moved, this metric supports the overall NEUTRAL verdict on AbbVie.

Frequently Asked Questions

Closest Sector Peers